@article{d11a4f2b851a4440bd6672ff226750ad,
title = "Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy",
keywords = "Aged, Antirheumatic Agents/administration & dosage, Bone Marrow Examination/methods, Dexamethasone/administration & dosage, Fatal Outcome, Humans, Immunoglobulins, Intravenous/administration & dosage, Infliximab/administration & dosage, Leishmaniasis, Visceral/diagnosis, Lymphohistiocytosis, Hemophagocytic/diagnosis, Male, Patient Care Management/methods, Sarcoidosis/drug therapy, Tumor Necrosis Factor-alpha/antagonists & inhibitors",
author = "Bukan, {K B} and A Nardo-Marino and C Hagdrup and M Boennelycke and Breinholdt, {M F} and C Sch{\"o}llkopf and Nielsen, {H V} and {El Fassi}, D",
year = "2019",
doi = "10.1080/03009742.2018.1533035",
language = "English",
volume = "48",
pages = "342--343",
journal = "Scandinavian Journal of Rheumatology",
issn = "0300-9742",
publisher = "Informa Healthcare",
number = "4",
}